Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related VC
8 Biggest Price Target Changes For Monday
Benzinga's Top Upgrades, Downgrades For February 27, 2017
Ford adjusts to new auto landscape (Seeking Alpha)
Related
Earnings Scheduled For December 13, 2016
Stock Offerings En Vogue Over Last Several Sessions
BioPharmX's (BPMX) Q4 2017 Results - Earnings Call Transcript (Seeking Alpha)

Analysts at Baird initiated coverage on Visteon Corp (NYSE: VC) with a Outperform rating. The target price for Visteon is set to $123. Visteon shares closed at $100.30 yesterday.

Analysts at Sterne Agee CRT initiated coverage of BioPharmX Corp (NYSE: BPMX) with a Buy rating. The target price for BioPharmX is set to $3.50. BioPharmX shares closed at $1.43 yesterday.

Analysts at William Blair initiated coverage on WhiteWave Foods Co (NYSE: WWAV) with a Outperform rating. WhiteWave Foods shares closed at $45.41 yesterday.

Canaccord Genuity initiated coverage on vTv Therapeutics Inc (NASDAQ: VTVT) with a Buy rating. The target price for vTv Therapeutics is set to $15. vTv Therapeutics shares closed at $9.50 yesterday.

UBS initiated coverage on Healthways, Inc. (NASDAQ: HWAY) with a Neutral rating. The target price for Healthways is set to $13. Healthways shares closed at $11.77 yesterday.

Analysts at Argus Research initiated coverage on Gannett Co Inc (NYSE: GCI) with a Hold rating. Gannett shares closed at $13.51 yesterday.

Analysts at Redburn initiated coverage on Priceline Group Inc (NASDAQ: PCLN) with a Buy rating. Priceline Group shares closed at $1,240.37 yesterday.

Latest Ratings for VC

DateFirmActionFromTo
Feb 2017CitigroupDowngradesBuyNeutral
Jan 2017Raymond JamesUpgradesMarket PerformOutperform
Dec 2016BMO CapitalInitiates Coverage OnMarket Perform

View More Analyst Ratings for VC
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (GCI + BPMX)

View Comments and Join the Discussion!